Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first-line treatment for advanced non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 656, doi. 10.1111/1759-7714.14304
- By:
- Publication type:
- Article
Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 4
Results: 18
1
2
Metastatic pulmonary nodule after a seventeen-year disease-free interval resected through thoracoscopic subsegmentectomy: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 653, doi. 10.1111/1759-7714.14316
- By:
- Publication type:
- Article
3
A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 648, doi. 10.1111/1759-7714.14314
- By:
- Publication type:
- Article
4
The rarest of rare cases within the one thousand faces of atypical carcinoid: Pseudomesotheliomatous manifestation in a pregnant woman.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 643, doi. 10.1111/1759-7714.14297
- By:
- Publication type:
- Article
5
Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1-ALK fusion.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 637, doi. 10.1111/1759-7714.14291
- By:
- Publication type:
- Article
6
Predictors of malignant lymph node involvement in patients with mediastinal lymphadenopathy and previous cancer: A cohort study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 631, doi. 10.1111/1759-7714.14311
- By:
- Publication type:
- Article
7
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 624, doi. 10.1111/1759-7714.14309
- By:
- Publication type:
- Article
8
Chronic obstructive pulmonary disease assessment test for the measurement of deterioration and recovery of health status of patients undergoing lung surgery.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 613, doi. 10.1111/1759-7714.14306
- By:
- Publication type:
- Article
9
Development of a deep learning-based method to diagnose pulmonary ground-glass nodules by sequential computed tomography imaging.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 602, doi. 10.1111/1759-7714.14305
- By:
- Publication type:
- Article
10
Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 593, doi. 10.1111/1759-7714.14303
- By:
- Publication type:
- Article
11
Circ_0026134 promotes NSCLC progression by the miR-3619-5p/CHAF1B axis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 582, doi. 10.1111/1759-7714.14301
- By:
- Publication type:
- Article
12
Circ_0007385 regulates cell proliferation, apoptosis and stemness via targeting miR-493-3p/RAB22A axis in non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 571, doi. 10.1111/1759-7714.14300
- By:
- Publication type:
- Article
13
Efficacy and safety of WBRT+EGFR-TKI versus WBRT only in the treatment of NSCLC patients with brain metastasis: An updated meta-analysis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 563, doi. 10.1111/1759-7714.14299
- By:
- Publication type:
- Article
14
Apatinib as maintenance therapy following standard first-line chemotherapy in extensive disease small cell lung cancer: A phase II single-arm trial.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 557, doi. 10.1111/1759-7714.14298
- By:
- Publication type:
- Article
15
Impact of sarcopenia on chemotherapy-triggered exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 549, doi. 10.1111/1759-7714.14294
- By:
- Publication type:
- Article
16
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 539, doi. 10.1111/1759-7714.14289
- By:
- Publication type:
- Article
17
Efficacy and safety of EBUS-TBNA under conscious sedation with meperidine and midazolam.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 533, doi. 10.1111/1759-7714.14286
- By:
- Publication type:
- Article
18
Association of the programmed death ligand-1 combined positive score in tumors and clinicopathological features in esophageal cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 523, doi. 10.1111/1759-7714.14285
- By:
- Publication type:
- Article